 Todd Getz
Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 18 | 2022 | 405 | 3.580 |
Why?
| | Blood Preservation | 7 | 2022 | 282 | 1.600 |
Why?
| | Cryopreservation | 3 | 2022 | 98 | 1.080 |
Why?
| | Platelet Aggregation | 6 | 2020 | 100 | 1.060 |
Why?
| | Hemostasis | 5 | 2023 | 82 | 0.680 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2013 | 455 | 0.680 |
Why?
| | Protein-Tyrosine Kinases | 3 | 2013 | 434 | 0.660 |
Why?
| | Suntan | 1 | 2019 | 1 | 0.630 |
Why?
| | Platelet Transfusion | 2 | 2020 | 67 | 0.620 |
Why?
| | Platelet Membrane Glycoproteins | 5 | 2013 | 37 | 0.590 |
Why?
| | Wounds and Injuries | 7 | 2024 | 752 | 0.500 |
Why?
| | Bleeding Time | 2 | 2015 | 7 | 0.490 |
Why?
| | Saphenous Vein | 2 | 2015 | 35 | 0.480 |
Why?
| | Blood Transfusion | 4 | 2024 | 324 | 0.460 |
Why?
| | Receptors, Thrombin | 2 | 2013 | 13 | 0.440 |
Why?
| | Vascular System Injuries | 1 | 2015 | 73 | 0.430 |
Why?
| | Dextran Sulfate | 1 | 2013 | 83 | 0.400 |
Why?
| | Blood Coagulation | 4 | 2019 | 254 | 0.400 |
Why?
| | Shock, Hemorrhagic | 2 | 2024 | 168 | 0.370 |
Why?
| | Threonine | 2 | 2010 | 46 | 0.360 |
Why?
| | Blood Component Removal | 2 | 2022 | 26 | 0.350 |
Why?
| | Flow Cytometry | 5 | 2019 | 1185 | 0.350 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 366 | 0.350 |
Why?
| | Myosin Light Chains | 1 | 2010 | 27 | 0.350 |
Why?
| | Carbazoles | 1 | 2011 | 83 | 0.340 |
Why?
| | Plateletpheresis | 3 | 2022 | 27 | 0.340 |
Why?
| | Serine | 1 | 2010 | 141 | 0.330 |
Why?
| | Apoptosis | 1 | 2019 | 2557 | 0.320 |
Why?
| | Platelet Activation | 6 | 2015 | 93 | 0.280 |
Why?
| | ABO Blood-Group System | 2 | 2024 | 51 | 0.270 |
Why?
| | Cold Temperature | 2 | 2020 | 177 | 0.270 |
Why?
| | Registries | 2 | 2024 | 2021 | 0.240 |
Why?
| | Thromboplastin | 2 | 2015 | 74 | 0.240 |
Why?
| | Resuscitation | 2 | 2024 | 250 | 0.230 |
Why?
| | Reactive Oxygen Species | 2 | 2019 | 619 | 0.220 |
Why?
| | Syk Kinase | 3 | 2013 | 21 | 0.210 |
Why?
| | Pulmonary Embolism | 2 | 2024 | 222 | 0.210 |
Why?
| | Lectins, C-Type | 3 | 2013 | 72 | 0.210 |
Why?
| | Trauma Centers | 1 | 2024 | 422 | 0.180 |
Why?
| | Thrombosis | 2 | 2015 | 368 | 0.180 |
Why?
| | Ticlopidine | 3 | 2015 | 52 | 0.170 |
Why?
| | Venous Thrombosis | 2 | 2024 | 187 | 0.170 |
Why?
| | Venous Thromboembolism | 1 | 2024 | 313 | 0.170 |
Why?
| | Thrombelastography | 2 | 2019 | 153 | 0.160 |
Why?
| | Mice, Knockout | 7 | 2018 | 3020 | 0.160 |
Why?
| | Quinolines | 1 | 2020 | 180 | 0.160 |
Why?
| | Isoenzymes | 2 | 2011 | 305 | 0.150 |
Why?
| | Platelet Count | 1 | 2019 | 86 | 0.150 |
Why?
| | Factor IX | 2 | 2018 | 48 | 0.150 |
Why?
| | Humans | 27 | 2024 | 137514 | 0.150 |
Why?
| | Hemostatics | 1 | 2019 | 52 | 0.150 |
Why?
| | Protein Kinase C | 2 | 2011 | 265 | 0.150 |
Why?
| | Protein S | 1 | 2018 | 9 | 0.150 |
Why?
| | Factor IXa | 1 | 2018 | 16 | 0.150 |
Why?
| | Primary Graft Dysfunction | 1 | 2017 | 30 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 566 | 0.140 |
Why?
| | Hemophilia B | 1 | 2018 | 61 | 0.140 |
Why?
| | Hemorrhage | 2 | 2023 | 723 | 0.140 |
Why?
| | Lactic Acid | 1 | 2019 | 306 | 0.140 |
Why?
| | Military Personnel | 1 | 2024 | 543 | 0.130 |
Why?
| | Calcium | 3 | 2013 | 1233 | 0.130 |
Why?
| | Platelet Aggregation Inhibitors | 3 | 2015 | 460 | 0.130 |
Why?
| | Emergency Medical Services | 1 | 2023 | 548 | 0.130 |
Why?
| | Heparin | 1 | 2018 | 259 | 0.130 |
Why?
| | Refrigeration | 1 | 2016 | 12 | 0.130 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2016 | 24 | 0.130 |
Why?
| | Solutions | 1 | 2016 | 170 | 0.120 |
Why?
| | rap1 GTP-Binding Proteins | 1 | 2015 | 4 | 0.120 |
Why?
| | Quality Improvement | 1 | 2024 | 1161 | 0.120 |
Why?
| | Platelet Glycoprotein GPIb-IX Complex | 1 | 2015 | 3 | 0.120 |
Why?
| | Talin | 1 | 2015 | 9 | 0.120 |
Why?
| | Platelet Adhesiveness | 1 | 2015 | 15 | 0.120 |
Why?
| | Microscopy, Video | 1 | 2015 | 26 | 0.120 |
Why?
| | Intravital Microscopy | 1 | 2015 | 25 | 0.110 |
Why?
| | Time Factors | 4 | 2024 | 6817 | 0.110 |
Why?
| | GTPase-Activating Proteins | 1 | 2015 | 82 | 0.110 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 73 | 0.110 |
Why?
| | Fibrinogens, Abnormal | 1 | 2014 | 4 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2066 | 0.110 |
Why?
| | Fibrin | 1 | 2015 | 80 | 0.110 |
Why?
| | Mice, Inbred C57BL | 5 | 2018 | 5792 | 0.110 |
Why?
| | Skin | 1 | 2019 | 751 | 0.110 |
Why?
| | Phosphorylation | 4 | 2013 | 1762 | 0.110 |
Why?
| | Peptides, Cyclic | 2 | 2013 | 260 | 0.110 |
Why?
| | Crotalid Venoms | 2 | 2011 | 31 | 0.110 |
Why?
| | Glucose | 1 | 2019 | 1018 | 0.110 |
Why?
| | Fibrinogen | 1 | 2014 | 170 | 0.100 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 402 | 0.100 |
Why?
| | Mitochondria | 2 | 2019 | 947 | 0.100 |
Why?
| | Laser Therapy | 1 | 2015 | 134 | 0.100 |
Why?
| | Signal Transduction | 5 | 2013 | 5096 | 0.100 |
Why?
| | Polysaccharides | 1 | 2013 | 87 | 0.100 |
Why?
| | Tyrosine | 1 | 2013 | 224 | 0.100 |
Why?
| | Bacteria | 1 | 2019 | 858 | 0.100 |
Why?
| | Arteries | 1 | 2014 | 269 | 0.100 |
Why?
| | Animals | 11 | 2018 | 37011 | 0.090 |
Why?
| | Blood Vessels | 1 | 2013 | 188 | 0.090 |
Why?
| | Cells, Cultured | 1 | 2019 | 4206 | 0.090 |
Why?
| | Mice | 9 | 2015 | 17843 | 0.090 |
Why?
| | Protein Binding | 2 | 2018 | 2229 | 0.090 |
Why?
| | Cell Shape | 1 | 2010 | 58 | 0.090 |
Why?
| | Adenosine Diphosphate | 1 | 2010 | 79 | 0.090 |
Why?
| | Peptides | 3 | 2011 | 986 | 0.080 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 501 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2016 | 895 | 0.080 |
Why?
| | Male | 12 | 2024 | 67718 | 0.080 |
Why?
| | rho-Associated Kinases | 1 | 2010 | 85 | 0.080 |
Why?
| | Kinetics | 2 | 2010 | 1679 | 0.080 |
Why?
| | Amino Acids, Aromatic | 1 | 2009 | 8 | 0.080 |
Why?
| | Liver Transplantation | 1 | 2017 | 872 | 0.080 |
Why?
| | Collagen Type IV | 1 | 2009 | 28 | 0.080 |
Why?
| | Carrier Proteins | 2 | 2011 | 770 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1108 | 0.080 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2010 | 171 | 0.080 |
Why?
| | Calcium Signaling | 1 | 2011 | 253 | 0.080 |
Why?
| | Protein Kinase C-delta | 1 | 2009 | 49 | 0.080 |
Why?
| | Female | 11 | 2024 | 73162 | 0.070 |
Why?
| | Protein Structure, Secondary | 1 | 2009 | 373 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2018 | 4295 | 0.070 |
Why?
| | Adult | 7 | 2024 | 37821 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2017 | 2641 | 0.060 |
Why?
| | Inflammation | 2 | 2014 | 2837 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2024 | 15628 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2011 | 920 | 0.060 |
Why?
| | United States Department of Defense | 1 | 2024 | 12 | 0.060 |
Why?
| | Thrombin | 2 | 2015 | 152 | 0.050 |
Why?
| | Blood Component Transfusion | 1 | 2024 | 84 | 0.050 |
Why?
| | Middle Aged | 6 | 2024 | 33355 | 0.050 |
Why?
| | Warfare | 1 | 2023 | 68 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2024 | 525 | 0.050 |
Why?
| | Thrombocytopenia | 2 | 2015 | 199 | 0.050 |
Why?
| | Benzothiazoles | 1 | 2020 | 33 | 0.040 |
Why?
| | Plasma | 1 | 2022 | 213 | 0.040 |
Why?
| | Survival Rate | 1 | 2024 | 1980 | 0.040 |
Why?
| | Aged | 4 | 2024 | 23798 | 0.040 |
Why?
| | Freeze Drying | 1 | 2019 | 82 | 0.040 |
Why?
| | Coagulants | 1 | 2018 | 19 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2018 | 211 | 0.040 |
Why?
| | Dental Anxiety | 1 | 1997 | 3 | 0.030 |
Why?
| | Anesthesia, Local | 1 | 1997 | 19 | 0.030 |
Why?
| | Anesthesia, Dental | 1 | 1997 | 22 | 0.030 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2018 | 151 | 0.030 |
Why?
| | Risk Factors | 2 | 2024 | 10356 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 411 | 0.030 |
Why?
| | Injections | 1 | 1997 | 182 | 0.030 |
Why?
| | Postoperative Period | 1 | 2017 | 344 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2019 | 684 | 0.030 |
Why?
| | Receptors, Purinergic P2Y12 | 1 | 2015 | 6 | 0.030 |
Why?
| | Thrombopoiesis | 1 | 2015 | 8 | 0.030 |
Why?
| | Lymphopenia | 1 | 2015 | 61 | 0.030 |
Why?
| | Splenectomy | 1 | 2015 | 62 | 0.030 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2015 | 66 | 0.030 |
Why?
| | Binding Sites | 1 | 2018 | 1310 | 0.030 |
Why?
| | Blood Coagulation Tests | 1 | 2014 | 67 | 0.030 |
Why?
| | Antithrombins | 1 | 2014 | 59 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5772 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2015 | 188 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2013 | 155 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 437 | 0.020 |
Why?
| | Cell Survival | 1 | 2016 | 1122 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2014 | 403 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2013 | 94 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2013 | 224 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2039 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1271 | 0.020 |
Why?
| | Length of Stay | 1 | 2017 | 1210 | 0.020 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2013 | 235 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 222 | 0.020 |
Why?
| | Hemophilia A | 1 | 2013 | 139 | 0.020 |
Why?
| | Phospholipase C gamma | 1 | 2010 | 29 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2013 | 338 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2010 | 116 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2013 | 429 | 0.020 |
Why?
| | Phenylalanine | 1 | 2009 | 68 | 0.020 |
Why?
| | Thromboxane A2 | 1 | 2009 | 11 | 0.020 |
Why?
| | Protein Kinase C-theta | 1 | 2009 | 1 | 0.020 |
Why?
| | Receptors, Proteinase-Activated | 1 | 2009 | 2 | 0.020 |
Why?
| | Crystallization | 1 | 2009 | 144 | 0.020 |
Why?
| | Qa-SNARE Proteins | 1 | 2009 | 20 | 0.020 |
Why?
| | Solubility | 1 | 2009 | 249 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2015 | 937 | 0.020 |
Why?
| | Anticoagulants | 1 | 2013 | 665 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2009 | 474 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3420 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2015 | 943 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2182 | 0.020 |
Why?
| | Oligopeptides | 1 | 2009 | 273 | 0.020 |
Why?
| | Antibodies | 1 | 2009 | 414 | 0.020 |
Why?
| | United States | 1 | 2024 | 14696 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 3964 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 2146 | 0.010 |
Why?
| | Gene Expression | 1 | 2010 | 1505 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2009 | 708 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2901 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2017 | 10821 | 0.010 |
Why?
| | Neoplasms | 1 | 2015 | 2666 | 0.010 |
Why?
| | Manifest Anxiety Scale | 1 | 1997 | 4 | 0.010 |
Why?
| | Escape Reaction | 1 | 1997 | 63 | 0.010 |
Why?
| | Disease Transmission, Infectious | 1 | 1997 | 61 | 0.010 |
Why?
| | Anesthetics, Local | 1 | 1997 | 80 | 0.010 |
Why?
| | Avoidance Learning | 1 | 1997 | 78 | 0.010 |
Why?
| | Pain Measurement | 1 | 1997 | 552 | 0.010 |
Why?
| | Data Collection | 1 | 1997 | 674 | 0.010 |
Why?
| | Pain | 1 | 1997 | 836 | 0.010 |
Why?
| | Cognition | 1 | 1997 | 1192 | 0.000 |
Why?
| | Adolescent | 1 | 1997 | 21555 | 0.000 |
Why?
|
|
Getz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|